Cost Effectiveness and Resource Allocation

Fig. 2 | Cost Effectiveness and Resource Allocation

Fig. 2

From: Cost-effectiveness analysis of Tocilizumab compared to Adalimumab in the treatment of severe active rheumatoid arthritis in Iran

Fig. 2

ISSN: 1478-7547

Contact us

General enquiries: journalsubmissions@springernature.com